| Monica Barman, MD,MPH | |
|
22 Bramhall St, Portland, ME 04102-3134 | |
| (207) 662-7060 | |
| (207) 662-6753 |
| Full Name | Monica Barman |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 22 Bramhall St, Portland, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720221302 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 70961-20 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Monica Barman, MD,MPH 17145j W Bluemound Rd # 169, Brookfield, WI 53005-5933 Ph: (207) 319-4113 | Monica Barman, MD,MPH 22 Bramhall St, Portland, ME 04102-3134 Ph: (207) 662-7060 |
News Archive
Very low doses of a drug used to treat certain types of cancer protect the insulin-producing cells in the pancreas and prevent the development of diabetes mellitus type 1 in mice. The medicine works by lowering the level of so-called sterile inflammation. The findings have been made by researchers from the University of Copenhagen, the Technical University of Denmark and the University of Southern Denmark working with researchers in Belgium, Italy, Canada, Netherlands and the USA.
Alexza Pharmaceuticals, Inc. announced today that the Company has scheduled an End-of Review meeting with the U.S. Food and Drug Administration in December to discuss the Complete Response Letter regarding the Company's New Drug Application for AZ-004 (Staccato loxapine).
Health Care REIT, announced today that it completed $3.2 billion of gross investments during calendar 2010. During the year, the company had dispositions of $196 million, resulting in 2010 net investments of $3.0 billion.
Researchers from Carnegie Mellon University's Computational Biology Department in the School of Computer Science have developed a new process that could reinvigorate the search for natural product drugs to treat cancers, viral infections and other ailments.
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
› Verified 6 days ago
Miss Wyki Gina Pang, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Department Of Medicine, Portland, ME 04102 Phone: 207-662-0111 |